Compound information
- Natural Products
- ZC592811
- Molecular Formula
- C14H17ClN2O5S
- Molecular Weight
- 360.054670324 g/mol
- Structure
-
- IUPAC Name
- [2-[4-chloro-3-(dimethylsulfamoyl)anilino]-2-oxo-ethyl] (E)-but-2-enoate
- InChI
- InChI=1S/C14H17ClN2O5S/c1-4-5-14(19)22-9-13(18)16-10-6-7-11(15)12(8-10)23(20,21)17(2)3/h4-8H,9H2,1-3H3,(H,16,18)/b5-4+
- InChI Key
- DQYVUMIKZZHATP-SNAWJCMRSA-N
- SMILES
- C/C=C/C(=O)OCC(=O)Nc1ccc(Cl)c(S(=O)(=O)N(C)C)c1
- Source
- ZINC000004986341
Warheads
- Acrylate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 23 | Ring Count | 1 |
Heteroatom Count | 9 | Rotatable Bond Count | 6 |
Hydrogen Bond Acceptor Count | 5 | Hydrogen Bond Donor Count | 1 |
Topological Polar Surface Area | 92.78 Å2 | LogP | 1.93 |
LogS | -3.145 | LogD | 2.099 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.133 | Pgp substrate | 0.997 |
HIA | 0.962 | F20 % | 0.988 |
F30 % | 0.767 | Caco-2 | -5.739 |
MDCK | -5.432 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.112 | PPB | 99.135 |
VD | 0.533 | Fu | 1.073 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.566 | CYP1A2 substrate | 0.677 |
CYP2A6 substrate | 0.553 | CYP2B6 substrate | 0.545 |
CYP2C19 inhibitor | 0.254 | CYP2C19 substrate | 0.818 |
CYP2C8 substrate | 0.846 | CYP2C9 inhibitor | 0.388 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.102 |
CYP2D6 substrate | 0.882 | CYP2E1 substrate | 0.255 |
CYP3A4 inhibitor | 0.065 | CYP3A4 substrate | 0.999 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.631 | CL | 11.148 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.151 | Hepatotoxicity | 0.969 |
Mutagenicity | 0.0 | Rat Oral Acute Toxicity | 0.011 |
FDAMDD | 0.209 | Skin Sensitization | 0.756 |
Carcinogenicity | 0.185 | Eye Corrosion | 0.003 |
Eye Irritation | 0.009 | Respiratory Toxicity | 0.599 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.466 | IGC50 | 3.519 |
LC50FM | 4.64 | LC50DM | 4.958 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.108 | NR-AR-LBD | 0.286 |
NR-AhR | 0.1 | NR-Aromatase | 0.1 |
NR-ER | 0.27 | NR-ER-LBD | 0.398 |
NR-PPAR-gamma | 0.675 | SR-ARE | 0.821 |
SR-ATAD5 | 0.422 | SR-HSE | 0.83 |
SR-MMP | 0.441 | SR-p53 | 0.791 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.